ArticleJournal of clinical pharmacology2019

Safety Exposure-Response Analysis for Daclatasvir, Asunaprevir, and Beclabuvir Combinations in HCV-Infected Subjects.

Mayu Osawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.